Results for tag: "Angina Pectoris Treatment"

The Angina Pectoris Treatment market within the context of Cardiovascular Drugs is a highly competitive market, with a wide range of products available. These products are used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart. Treatment options include lifestyle changes, medications, and surgical procedures. Medications used to treat angina pectoris include nitrates, beta-blockers, calcium channel blockers, and antiplatelet agents. These medications are used to reduce the frequency and severity of angina attacks, as well as to reduce the risk of heart attack and stroke. The Angina Pectoris Treatment market is driven by the increasing prevalence of cardiovascular diseases, the growing elderly population, and the increasing awareness of the importance of preventive healthcare. Some of the major companies in the Angina Pectoris Treatment market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more